Log in

Sanofi Ventures
Helgi van de Velde

Helgi van de Velde

Head Of Hematologic Malignancies Strategies And Late Development at Sanofi Ventures

About

Links

Org chart

View in org chart

Manager

Stephen Kuske

Vice President, Global Head Of Pharmacovigilance Operations

Peers

Marta Amaral

Head High Throughput Protein Engineering

View in org chart

Timeline

Head Of Hematologic Malignancies Strategies And Late Development
November, 2022 - present
Vice President Global Program Head Multiple Myeloma
October, 2019
Vice President - Global Clinical Dev Lead Isatuximab Myeloma, Global Project Head Nextgen Cd38
February, 2018

A panel showing how The Org can help with contacting the right person.